Atlas Venture Advisors, Inc. Long-Term Concentrated

CIK: 0001767432 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 11, 2020

Total Value ($000): $66,190 (100.0% shares, 0.0% debt)

Holdings (7)

— TRANSLATE BIO INC 48.2%

Value ($000) $31,925 Shares 3,922,008 Est. Cost $7.50 Unrealized —

BCYC BICYCLE THERAPEUTICS PLC 19.4%

Value ($000) $12,850 Shares 1,362,696 Est. Cost $10.06 Unrealized —

ROKU ROKU INC 11.7%

Value ($000) $7,727 Shares 57,707 Est. Cost $137.43 Unrealized 0.0%

DDOG DATADOG INC 6.5%

Value ($000) $4,278 Shares 113,232 Est. Cost $34.77 Unrealized +3.5%

SNAP SNAP INC 6.1%

Value ($000) $4,010 Shares 245,559 Est. Cost $6.50 Unrealized +126.3%

— ZAFGEN INC 5.9%

Value ($000) $3,892 Shares 3,506,207 Est. Cost $4.95 Unrealized —

— MIRAGEN THERAPEUTICS INC 2.3%

Value ($000) $1,508 Shares 3,142,580 Est. Cost $3.03 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	TRANSLATE BIO INC	3,922,008	$31,925	48.2%	$7.50	—	COM	89374L104
BCYC	BICYCLE THERAPEUTICS PLC	1,362,696	$12,850	19.4%	$10.06	—	SPONSORED ADS	088786108
ROKU	ROKU INC	57,707	$7,727	11.7%	$137.43	0.0%	COM CL A	77543R102
DDOG	DATADOG INC	113,232	$4,278	6.5%	$34.77	+3.5%	CL A COM	23804L103
SNAP	SNAP INC	245,559	$4,010	6.1%	$6.50	+126.3%	CL A	83304A106
—	ZAFGEN INC	3,506,207	$3,892	5.9%	$4.95	—	COM	98885E103
—	MIRAGEN THERAPEUTICS INC	3,142,580	$1,508	2.3%	$3.03	—	COM	60463E103